Literature DB >> 1757960

Ehlers-Danlos syndrome type IV: phenotypic consequences of a splicing mutation in one COL3A1 allele.

D O Sillence1, A A Chiodo, P E Campbell, W G Cole.   

Abstract

The features of a child with Ehlers-Danlos syndrome type IV (EDS IV) resulting from a mutation in one COL3A1 allele were studied. The child was heterozygous for a G- to A-transition at the splice donor site of intron 41. It resulted in the splicing out of the exon 41 encoded sequence from alpha 1(III) mRNA and the deletion of 36 amino acids from glycine775 to lysine810 of the triple helical domain of alpha 1(III) chains of type III collagen. The amount of type III collagen in the dermis was only about 11% of normal. The child had the acrogeric form of EDS IV. He had the characteristic facies with a pinched nose, thin lips, and prominent eyes. These facial features, his aesthenic build, thin skin, prominent subcutaneous veins, and aged hands produced a 'cachectic' appearance. These features were evident in early childhood and worsened up to 12 1/2 years when he was last reviewed. Spontaneous bruising, bleeding from the large bowel, constipation, and delayed gastric emptying were other features. In cross section, the dermal collagen fibrils were round and measured 93.3 +/- 11.5 nm in diameter which was not significantly different from control values of 102.5 +/- 13.4 nm. The serum type III procollagen amino-terminal propeptide level of 25.5 ng/ml was within the normal age matched values of 15.5 +/- 7.7 ng/ml despite the low production of type III collagen by cultured fibroblasts. The child probably had a spontaneous new mutation in one COL3A1 allele as only normal sequences were obtained from the corresponding amplified region of the parent's leucocyte DNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757960      PMCID: PMC1017161          DOI: 10.1136/jmg.28.12.840

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  18 in total

Review 1.  Type III collagen mutations in Ehlers Danlos syndrome type IV and other related disorders.

Authors:  F M Pope; A C Nicholls; P Narcisi; A Temple; Y Chia; P Fryer; A De Paepe; W P De Groote; J R McEwan; D A Compston
Journal:  Clin Exp Dermatol       Date:  1988-09       Impact factor: 3.470

2.  Low levels of serum type III procollagen aminoterminal propeptide confirmed type III collagen deficiency in patients without typical clinical symptoms of Ehlers-Danlos type IV.

Authors:  K M Dyne; G Zanaboni; G Annoni; M P De Agostini; G Cetta
Journal:  Eur J Clin Invest       Date:  1989-08       Impact factor: 4.686

3.  The clinical features of Ehlers-Danlos syndrome type VII due to a deletion of 24 amino acids from the pro alpha 1(I) chain of type I procollagen.

Authors:  W G Cole; R Evans; D O Sillence
Journal:  J Med Genet       Date:  1987-11       Impact factor: 6.318

4.  Variants of the Ehlers-Danlos syndrome. Clinical, biochemical, haematological, and chromosomal features of 100 patients.

Authors:  P Beighton; A Price; J Lord; E Dickson
Journal:  Ann Rheum Dis       Date:  1969-05       Impact factor: 19.103

5.  Ehlers-Danlos syndrome type IV: a multi-exon deletion in one of the two COL3A1 alleles affecting structure, stability, and processing of type III procollagen.

Authors:  A Superti-Furga; E Gugler; R Gitzelmann; B Steinmann
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

6.  Single base mutation in the type III procollagen gene that converts the codon for glycine 883 to aspartate in a mild variant of Ehlers-Danlos syndrome IV.

Authors:  G Tromp; H Kuivaniemi; C Stolle; F M Pope; D J Prockop
Journal:  J Biol Chem       Date:  1989-11-15       Impact factor: 5.157

7.  A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV.

Authors:  W G Cole; A A Chiodo; S R Lamande; R Janeczko; F Ramirez; H H Dahl; D Chan; J F Bateman
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

8.  Spontaneous arterial perforation: the Ehlers-Danlos specter.

Authors:  D F Cikrit; J H Miles; D Silver
Journal:  J Vasc Surg       Date:  1987-02       Impact factor: 4.268

9.  A single base mutation that substitutes serine for glycine 790 of the alpha 1 (III) chain of type III procollagen exposes an arginine and causes Ehlers-Danlos syndrome IV.

Authors:  G Tromp; H Kuivaniemi; H Shikata; D J Prockop
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

10.  Type III collagen can be present on banded collagen fibrils regardless of fibril diameter.

Authors:  D R Keene; L Y Sakai; H P Bächinger; R E Burgeson
Journal:  J Cell Biol       Date:  1987-11       Impact factor: 10.539

View more
  1 in total

1.  Congenital erythropoietic porphyria: identification and expression of 10 mutations in the uroporphyrinogen III synthase gene.

Authors:  W Xu; C A Warner; R J Desnick
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.